Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
November 07, 2024 08:19 ET
|
Trinity Biotech plc
DUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
October 25, 2024 08:45 ET
|
Trinity Biotech plc
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture
October 25, 2024 08:45 ET
|
Trinity Biotech plc
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
October 07, 2024 08:15 ET
|
Trinity Biotech plc
DUBLIN, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
September 24, 2024 16:05 ET
|
Trinity Biotech plc
-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict the risk of preeclampsia in pregnant women- ...
Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer
September 18, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...
Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology
September 09, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer
September 03, 2024 09:55 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales
August 26, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director
August 20, 2024 17:00 ET
|
Trinity Biotech plc
DUBLIN, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including...